Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Survival Features, Prognostic Factors, and Determinants of Diagnosis and Treatment Among Iranian Patients With Pancreatic Cancer, a Prospective Study Publisher Pubmed



Sheikh M1, 2 ; Masoudi S3 ; Bakhshandeh R3 ; Moayyedkazemi A3, 4 ; Zamani F5 ; Nikfam S3 ; Mansouri M3 ; Shishavan NG3 ; Nikeghbalian S6 ; Brennan P2 ; Malekzadeh R1, 3 ; Pourshams A1, 3, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Section of Genetics, International Agency for Research on Cancer, World Health Organization, Lyon, France
  3. 3. Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Internal Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
  5. 5. Gastrointestinal and Liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Hepatobiliary Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
  7. 7. Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran

Source: PLoS ONE Published:2020


Abstract

Objectives Investigating the survival features, and determinants of treatment and stage at presentation in Iran Methods 461 patients with pancreatic ductal adenocarcinoma (PC) were prospectively enrolled from Shariati hospital, Tehran, Iran, between 2011–2018. All patients underwent endoscopic ultrasonography, computed tomography scanning, and physical examination. Validated questionnaire was completed for the participants and all were actively followed on monthly basis. Results Median survival time was 6.5 months, and 1-, and 5-year survival rates were 26.2%, and 1.5%. Patients who were older (p<0.001), illiterate (p = 0.004), unmarried (p = 0.003), rural inhabitant (p = 0.013), opium user (p = 0.039), and had lower body mass index (BMI) (p = 0.002) had lower overall survival. Tumors located in the head of pancreas were more commonly diagnosed at lower stages (p<0.001). Only 10.4% of patients underwent surgery who were more commonly educated (p<0.001), married (p = 0.005), had a tumor located in the head of pancreas (p = 0.016), and were diagnosed at lower stages (p<0.001). After adjustment for potential confounders and risk factors, rural inhabitance (HR: 1.33 (95% CI: 1.01–1.74)), having more symptoms (HR for each increasing symptom: 1.06 (1.02–1.11)), using opium (HR: 1.51 (1.04–2.20)), having a tumor located in the body of pancreas (HR: 1.33 (1.02–1.75)), and having an advanced tumor stage (HR: 2.07 (1.34–3.19)) remained significantly associated with increased risk of mortality. After the adjusting for potential confounders, we did not find significant relationships between smoking, alcohol intake, and BMI with the risk of death among patients with pancreatic cancer. Conclusions Iranian patients with PC have very poor long-term survival. Besides tumor’s stage and location, socioeconomic disparities could affect the probabilities of receiving treatment and/or survival in these patients. Opium use is an independent risk factor for mortality among PC patients in Iran. © 2020 Sheikh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Other Related Docs
22. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
26. Tumor Immunology, Clinical Immunology (2022)
29. Ambient Air Pollution Exposure and Thyroid Cancer Incidence in Iran, Journal of Air Pollution and Health (2021)